Speaker Profile
Wesley Blackaby

Wesley Blackaby PhD

Biochemistry and Molecular Genetics
Cambridge, England, United Kingdom

Connect with the speaker?

Wesley is VP of Chemistry at STORM Therapeutics and is responsible for all chemistry-related operations. Wesley brings over 20 years’ industrial experience in drug discovery gained in the pharmaceutical and contract research sectors. Wesley began his industrial career within process chemistry at Glaxo-Wellcome in Dartford before moving to Merck Sharpe and Dohme (MSD) in 1996.

At MSD, Wesley worked on several programs which reached clinical trials for schizophrenia and anxiety disorders. On leaving MSD in 2006 he joined BioFocus, part of the Galapagos group, advancing in project leadership roles culminating as Senior Director in Medicinal Chemistry, and was responsible for maintaining large multidisciplinary collaborations, overseeing the delivery of multiple drug discovery projects and pre-clinical candidates.

Wesley has extensive experience across a wide range of therapeutic areas and drug target classes in lead identification, lead optimization and candidate nomination. Wesley completed his BSc in Chemistry at the University of Southampton followed by Ph.D. studies under the joint supervision of Prof. Chris McGuigan (University College Cardiff) and Prof. George Attard (University of Southampton). Wesley has co-authored over 40 patent applications and papers.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)